The Oncology Institute, Inc.
TOI
$3.31
$0.082.48%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 49.67M | 47.40M | 46.36M | 65.83M | 82.86M |
Total Receivables | 48.68M | 54.86M | 54.37M | 59.13M | 42.91M |
Inventory | 10.04M | 10.11M | 11.32M | 11.55M | 13.68M |
Prepaid Expenses | 4.03M | 4.06M | 4.16M | 4.68M | 4.05M |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 112.42M | 116.43M | 116.21M | 141.19M | 143.49M |
|
|||||
Total Current Assets | 112.42M | 116.43M | 116.21M | 141.19M | 143.49M |
Net Property, Plant & Equipment | 37.67M | 39.36M | 39.22M | 38.41M | 40.05M |
Long-term Investments | 7.23M | 7.23M | 7.23M | 7.23M | 7.23M |
Goodwill | 7.23M | 7.23M | 7.23M | 7.23M | 7.23M |
Total Other Intangibles | 14.81M | 15.58M | 16.36M | 17.13M | 17.90M |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 589.00K | 588.00K | 582.00K | 568.00K | 561.00K |
Total Assets | 172.72M | 179.18M | 179.60M | 204.53M | 209.24M |
|
|||||
Total Accounts Payable | 24.32M | 24.57M | 15.75M | 21.02M | 14.43M |
Total Accrued Expenses | 12.98M | 8.44M | 6.28M | 8.06M | 10.70M |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 6.84M | 6.79M | 6.56M | 6.43M | 6.36M |
Total Finance Division Other Current Liabilities | 8.08M | 6.96M | 6.51M | 10.26M | 3.30M |
Total Other Current Liabilities | 8.08M | 6.96M | 6.51M | 10.26M | 3.30M |
Total Current Liabilities | 52.22M | 46.76M | 35.10M | 45.77M | 34.79M |
|
|||||
Total Current Liabilities | 52.22M | 46.76M | 35.10M | 45.77M | 34.79M |
Long-Term Debt | 93.13M | 91.54M | 89.95M | 88.39M | 86.83M |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 23.29M | 24.74M | 24.62M | 25.15M | 26.49M |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 495.00K | 671.00K | 728.00K | 3.93M | 4.12M |
Total Liabilities | 169.13M | 163.70M | 150.40M | 163.24M | 152.22M |
|
|||||
Common Stock & APIC | 215.42M | 214.13M | 211.74M | 208.35M | 204.19M |
Retained Earnings | -210.81M | -197.63M | -181.52M | -166.04M | -146.15M |
Treasury Stock & Other | -1.02M | -1.02M | -1.02M | -1.02M | -1.02M |
Total Common Equity | 3.59M | 15.48M | 29.21M | 41.30M | 57.03M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 3.59M | 15.48M | 29.21M | 41.30M | 57.03M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 3.59M | 15.48M | 29.21M | 41.30M | 57.03M |
|